| Adipocytokines: mediators linking adipose tissue, inflammation and immunity H Tilg, AR Moschen Nature reviews immunology 6 (10), 772-783, 2006 | 4026 | 2006 |
| Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis H Tilg, AR Moschen Hepatology 52 (5), 1836-1846, 2010 | 2717 | 2010 |
| Visfatin, an adipocytokine with proinflammatory and immunomodulating properties AR Moschen, A Kaser, B Enrich, B Mosheimer, M Theurl, H Niederegger, ... The Journal of Immunology 178 (3), 1748-1758, 2007 | 1366 | 2007 |
| Inflammatory mechanisms in the regulation of insulin resistance H Tilg, AR Moschen Molecular medicine 14, 222-231, 2008 | 1171 | 2008 |
| NAFLD and diabetes mellitus H Tilg, AR Moschen, M Roden Nature reviews Gastroenterology & hepatology 14 (1), 32-42, 2017 | 948 | 2017 |
| Microbiota and diabetes: an evolving relationship H Tilg, AR Moschen Gut 63 (9), 1513-1521, 2014 | 870 | 2014 |
| European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ... Journal of Crohn's and Colitis 3 (2), 47-91, 2009 | 697 | 2009 |
| The intestinal microbiota in colorectal cancer H Tilg, TE Adolph, RR Gerner, AR Moschen Cancer cell 33 (6), 954-964, 2018 | 678 | 2018 |
| Insulin resistance, inflammation, and non-alcoholic fatty liver disease H Tilg, AR Moschen Trends in Endocrinology & Metabolism 19 (10), 371-379, 2008 | 605 | 2008 |
| Adiponectin and its receptors in non-alcoholic steatohepatitis S Kaser, A Moschen, A Cayon, A Kaser, J Crespo, F Pons-Romero, ... Gut 54 (1), 117-121, 2005 | 599 | 2005 |
| Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease C Grander, TE Adolph, V Wieser, P Lowe, L Wrzosek, B Gyongyosi, ... Gut 67 (5), 891-901, 2018 | 535 | 2018 |
| Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction MM Richardson, JR Jonsson, EE Powell, EM Brunt, ... Gastroenterology 133 (1), 80-90, 2007 | 514 | 2007 |
| Gut microbiome and liver diseases H Tilg, PD Cani, EA Mayer Gut 65 (12), 2035-2044, 2016 | 512 | 2016 |
| IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting AR Moschen, H Tilg, T Raine Nature Reviews Gastroenterology & Hepatology 16 (3), 185-196, 2019 | 392 | 2019 |
| Gut, inflammation and osteoporosis: basic and clinical concepts H Tilg, AR Moschen, A Kaser, A Pines, I Dotan Gut 57 (5), 684-694, 2008 | 367 | 2008 |
| Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases H Tilg, AR Moschen Clinical science 114 (4), 275-288, 2008 | 359 | 2008 |
| Interleukin‐1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis H Tilg, AR Moschen, G Szabo Hepatology 64 (3), 955-965, 2016 | 322 | 2016 |
| Lipocalin-2: a master mediator of intestinal and metabolic inflammation AR Moschen, TE Adolph, RR Gerner, V Wieser, H Tilg Trends in Endocrinology & Metabolism 28 (5), 388-397, 2017 | 321 | 2017 |
| Food, immunity, and the microbiome H Tilg, AR Moschen Gastroenterology 148 (6), 1107-1119, 2015 | 318 | 2015 |
| Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor α expression AR Moschen, C Molnar, S Geiger, I Graziadei, CF Ebenbichler, H Weiss, ... Gut 59 (9), 1259-1264, 2010 | 300 | 2010 |
Romana R. GernerTechnical University of Munich在 tum.de 的电子邮件经过验证
Romana R. GernerTechnical University of Munich在 tum.de 的电子邮件经过验证